Tim Draper keeps defending Theranos - Axios
Featured

Tim Draper keeps defending Theranos

JD Lasika / Flickr

Theranos has become compagnia non grata in Silicon Valley, a troubled reminder that not even multi-billion dollar valuations can save a startup from its own short-cuts. But it still has at least one vocal defender: Venture capitalist Tim Draper, an old family friend of Theranos founder and CEO Elizabeth Holmes, who led an early $1 million investment into the company (split between two investment firms). In short, he believes the attacks on Theranos are "a witch hunt."

If you don't know Theranos, here's the nutshell:

  • Blood-testing company founded in 2003 by Stanford drop-out Elizabeth Holmes, promising it needed just a few drops to conduct hundreds of tests.
  • Valued by private investors at $9 billion by 2014, and signed a major partnership with Walgreens. Board members included Henry Kissinger and incoming Defense Sec. James Mattis.
  • Subject of a series of critical Wall Street Journal articles by John Carreyrou, the first of which showed that the company's technology was so troubled that it regularly used third-party machines that required standard blood draws.
  • Regulators have banned Holmes from owning or operating a lab (something she's appealing) and the company now wants to sell "mini-labs" to other providers instead of offering blood tests itself. More than 500 employees have been laid off. Walgreens is suing for breach of contract and certain investors are suing for fraud.
  • Carreyrou is now writing a book about Theranos, which has been optioned for a film that will star Jennifer Lawrence.

Draper recently spoke to Axios about why he believes Holmes, not his fellow investors or the company's users, are the real victims. Here's the interview (slightly edited for clarity):

Axios: Did you primarily invest in Theranos because of Elizabeth Holmes, or because of the technology?

Draper: "There are a lot of things that go through our minds when we're making investments in new startups and what I tend to do is focus on great opportunities that can transform industries. In this case, Elizabeth came in and said, 'I'm going to transform healthcare as we know it.' She was very dynamic and answered all of our questions to our satisfaction. It was just getting started, which is why our investment was so small."

Did you pass up the chance to reinvest, or did she not give you the option?"

"No, we never really had another opportunity."

The first Wall Street Journal story critical of Theranos was published in October 2015. What was your initial reaction?

"I dismissed it because there are always writers who want to take down big successes. Then after the next one I realized there was some strange vendetta. Maybe it had to do with money. The guy is getting $4 million to continue this charade."

Don't journalists sometimes dig into something that only looks like a big success, but actually is fraudulent in some way?

"Elizabeth started an amazing company that is so disruptive to various industries, so I think there were competitors fueling this fire. She was delivering 50 blood tests for $30. Her competitors are delivering the same thing for hundreds, sometimes thousands of dollars. They were hugely threatened by this. Her product allowed consumers to have a baseline and then measure all of the changes in their blood over time. That technology is going to happen and I'm hoping it happens with Theranos.

It's like other industries that get threatened by new technology. Like Bitcoin when all of the banks lined up against it. Or Uber being attacked by the taxi companies or Tesla by the car companies or Skype by the telecom companies. In this case, the competitors got a mouthpiece. I believe Elizabeth is the victim of a witch hunt."

You said something similar to Bloomberg TV last summer, adding that the competitors in this case included pharma and health insurers. How so?

"My argument there is a little more abstract. If you're big pharma, you like this relationship you have with doctors. You like that you can drive what people are prescribed. Theranos allows people to take more control over their own health, which would end up creating smaller markets for drug companies and health insurance companies."

Isn't there intrinsic value in having a trained medical professional involved in some level of decision-making? If Theranos makes a mistake, a doctor is more likely to spot the abnormality than a layperson.

"Do you know how many mistakes Labcorp makes?"

No, but I do know that Theranos was making errors in excess of its own internal standards.

"I like that they're self-policing."

They have to be, by law. But you weren't concerned that they were sometimes several standard deviations off of where they believed they needed to be? Or that they didn't quickly inform patients when results were incorrect?

"There are plenty of customer service groups that don't respond to calls right away, and this is a small company. Maybe they were distracted because they're under attack. But, obviously, you need to be a really good communicator when you're a startup in the medical field, and that's something they'll learn over time.

Dan, you've been covering startups for years. They make a big impact on the world, make all of our lives so much better. When an industry gets transformed, people who work for the status quo have lives that get challenged. They will do whatever it takes to take down the source of the transformation. In this case, that Wall Street Journal writer keeps pounding away but there isn't anything there."

Much of his reporting was based on findings of federal regulators.

"Those regulators were compelled to go in there and find something because of the Journal."

But Theranos then voided thousands of its own tests. Isn't that an obvious admission of messing up with people's health?

"Voiding the tests was a business decision. Look, Tylenol once had to recall capsules because someone had been poisoning them. If things aren't working, you retrench and then return to market. Attacking a company like this is awful."

Would you at least concede that Theranos was sloppy?

"I don't think so. If it wasn't for all this I could have had a really nice trend-line of 50 blood tests, which would have been a great opportunity for me to have better healthcare. It's not something my doctor is doing."

You've said in this interview that the WSJ has a vendetta against Theranos. Leaving aside that Rupert Murdoch was an investor, why would it be out to get Elizabeth Holmes or her company?

"Well, they first say: 'There's a great woman entrepreneur and she's on the cover of Forbes. Let's see what we can do to take her down.' Then there are competitors who want to help take the company down and soon it becomes like the Heisenberg Uncertainty Principle, because the Journal is involved in the experiment so it's no longer a pure experiment. By continuing to publish negative stories about Theranos, it created negative effects. It's like that old thing when NBC News caused a truck to catch fire -- it's the press creating a series of events that negatively impact technology, progress and our economy. And [Carreyrou] ends up getting $4 million."

But that's not the reporting chronology, according to Carreyrou. He says a disgruntled employee came to them.

"Oh, a disgruntled employee. Well why was he disgruntled? Could that be why he decided to attack the company?"

He was the grandson of a board member, and believed there were serious problems with what was happening in the Theranos lab. Have you read the piece about that?

"No, I haven't."

Can Theranos survive, and would you invest again if given the opportunity?

"Sorry, I only had 30 minutes for this and really need to go."

Featured

World Bank president comments on Ivanka Trump's investment fund

Michael Sohn/ AP via pool

World Bank Group president Jim Yong Kim has released a statement about Ivanka Trump's involvement in a fund for women entrepreneurs to be administered by the World Bank (which Trump told our own Mike Allen about on Tuesday):

"The World Bank Group is working with partners on the details around creating a facility for women's economic empowerment, specifically through providing access to finance, markets, and networks. Typically, the governance of facilities we manage is decided among donors, and the secretariat sits within and is administered by the World Bank Group. We are very grateful for the leadership Ms. Trump and Chancellor Merkel have demonstrated on this important issue."

Axios' Dan Primack still has some questions about the fund, including whether Trump or adviser Dina Powell will be actively soliciting contributions while working in the White House.

Featured

Juno, the 'anti-Uber' startup, sells to Gett for $200 million

Courtesy of Gett

Before Juno even made it beyond New York City, the ride-hailing company has already sold to Gett, a competitor headquartered in Israel and with operations in Europe. The two will team up to tackle NYC, and eventually expand to more U.S. cities.

One notable piece of the $200 million acquisition is that Juno is rescinding the restricted stock unit program for drivers it rolled out last summer, and will send a one-time payment to participating drivers. The RSU program was the differentiator that immediately attracted the most attention when Juno first opened up shop last year, advertising itself as the "anti-Uber."

Broken promise? The combined company won't roll out any equity program to drivers in the future, instead focusing on rewarding loyal drivers in other ways, such as cash bonuses, a Juno spokesperson confirmed to Axios via email. The company added that it realized even before the sale that implementing the program turned out to be more difficult than anticipated.

Opposing views: Shortly after the deal was announced, the Independent Drivers Guild in NYC expressed disappointment in the company's move, calling it a "bait-and-switch." Juno, on the other hand, maintains that while the equity compensation was important, it wasn't its only differentiator. "Juno is about the unique culture we created, about the way we treat drivers and riders, about our 24/7 live support, about a fair lower commission," the spokesperson said via email, adding that these aspects will "only get better."

Featured

Just 36% say they'd vote to re-elect Trump

Evan Vucci / AP

Only 36% of people say they would vote to re-elect President Trump if the 2020 election were today, per a Fox news poll, compared to 55% who would vote for someone else.

Most have already made up their minds: 21% say they would definitely vote for Trump and 47% would definitely vote for someone else.

At this point in his first term, 52% said they'd vote to re-elect Barack Obama, and 31% said they'd vote for someone else.

Featured

Trump says he's considering breaking up the 9th Circuit

Carolyn Kaster / AP

President Trump has told the Washington Examiner he is "absolutely" considering breaking up the 9th Circuit, where judges have struck down both his travel ban and sanctuary cities order.

"There are many people that want to break up the 9th Circuit. It's outrageous.... Everybody immediately runs to the 9th Circuit. And we have a big country. We have lots of other locations. But they immediately run to the 9th Circuit. Because they know that's like, semi-automatic."

The circuit includes... Alaska, Arizona, California, Hawaii, Idaho, Montana, Nevada, Oregon and Washington and is by far the largest of the 13 appellate circuits.

Deep breath: It's not clear that splitting the court in two would be particularly helpful to Trump, or that this is something he's actually inclined to move ahead with.

Featured

Instagram growth explodes

Instagram announced Wednesday that it has amassed 700 million monthly active users (MAU) since launching in 2010, a more than 16% increase in just four months, and a 40% increase in one year.

Data: Instagram; Chart: Andrew Witherspoon / Axios

Why it matters: Instagram announced the growth achievement the same day Twitter reported its Q1 earnings, where it touted a 2.8% quarterly increase in monthly active users to to 328 million — still less than half of the user base of Instagram, which is four years younger. Instagram rival Snapchat will also be taking note of these numbers, as its audience has dwindled since Instagram launched a copycat stories feature in August. Instagram's stories audience has increased so quickly that it surpassed Snapchat's total audience by nearly 40 million MAU a few weeks ago.

Featured

White House, Dems reach truce on insurer payments

Carolyn Kaster / AP

There's been a lot of buzz this afternoon about the White House supposedly promising to continue the Affordable Care Act's insurer payments. The reality is that it's only going to continue the payments "for now," per a White House official.
But that was enough to convince House Minority Leader Nancy Pelosi, who had clashed with Office of Management and Budget Director Mick Mulvaney over the issue, to dial down the threats of a government shutdown.
From the White House: "While we agreed to go ahead and make the CSR payments for now, we haven't made a final decision about future commitments."
From Pelosi: "Our major concerns in these negotiations have been about funding for the wall and uncertainty about the CSR payments crucial to the stability of the marketplaces under the Affordable Care Act. We've now made progress on both of these fronts ... Our appropriators are working in good faith toward a bipartisan proposal to keep government open."
Behind the scenes: Pelosi talked to White House chief of staff Reince Priebus this afternoon, who has been more conciliatory on the spending bill negotiations than Mulvaney.
Featured

WH considers labeling North Korea a state sponsor of terrorism

Wong Maye-E / AP

A senior White House official said the U.S. is considering adding North Korea to the list of state sponsors of terrorism, per Reuters.

The club: North Korea would be joining Iran, Sudan, and Syria. It was de-listed as a state sponsor in 2008 after agreeing to scale back its nuclear program.

Context: Defense Secretary Mattis, Secretary of State Rex Tillerson, DNI Dan Coats, and Joint Chiefs Chairman Joesph Dunford are briefing Senators in at the White House today on North Korea.

Featured

Al Gore says better than 50-50 chance Trump decides to stay in Paris climate accord

Emily Pidgeon/TED

Odds are that the U.S. will remain a party to the Paris climate accord former Vice President Al Gore said Wednesday In a brief appearance at the TED conference in Vancouver.

"I think there is a better than 50-50 chance the Trump administration will decide to stay in the Paris agreement," Gore said. "I don't know that for sure."

Gore said there is a debate taking place tomorrow inside the White House with a decision set to be announced the third week in May before a G-20 summit. "I think the odds are they will decide to stay in Paris agreement. I certainly hope so."

The backdrop: Gore's comments came during an entire session devoted to the impact on climate change. Discussions ranged from more accurate pictures of the crisis to weighing radical solutions, including shooting chalk into the atmosphere in order to reduce the amount of sunlight heating the earth. That idea drew criticism from Gore and others.

Featured

Trump has filled 5% of his senior administration jobs

Carolyn Kaster/AP

Of the 556 seats that have to be nominated by President Trump and confirmed by the Senate:

  1. 530 seats are empty
  2. 20 Cabinet-level seats filled, 2 await confirmation, 1 failed
  3. 37 nominees awaiting confirmation
  4. 468 seats have no nominations

The precedent: at the 100-day mark, Obama had 487 empty, George W. Bush 521, and Clinton 507

Featured

99% of women founders don't use VC funding

Marius Boatca via Flickr CC

Only 1% of female founders use venture capital funding to back their businesses, according to an Ernst & Young (EY) and Women's Presidents' Organization (WPO) report, obtained by Fortune. The study looked at 430 women-owned businesses over their lifetime, including old and new companies, and found that:

  • 8% of the women are using personal savings instead of VC funding
  • 22% incurred personal debt
  • 18% received a loan from friends or family

Why not: Co-founder of EY's Entrepreneurial Women program said some women don't seek out venture capital funding in the first place and see it as a point of pride and a source of control — 100% ownership of the business.

Where it stands: 2.19% of all venture capital funding went to women last year, which is a smaller percentage than almost every year in the last decade.